|
Volumn 295, Issue 14, 2006, Pages 1629-1631
|
Researchers focus on improving treatments for acute ischemic stroke
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISUFENTON SODIUM;
NEUROPROTECTIVE AGENT;
PLACEBO;
TISSUE PLASMINOGEN ACTIVATOR;
ANTIOXIDANT;
BENZENESULFONIC ACID DERIVATIVE;
FIBRINOLYTIC AGENT;
NITROGEN OXIDE;
BLEEDING;
CATHETER;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
HEART DISEASE;
HUMAN;
IMAGING;
MEDICAL RESEARCH;
MORBIDITY;
MORTALITY;
PILOT STUDY;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SHORT SURVEY;
TREATMENT OUTCOME;
ULTRASOUND;
ARTICLE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ULTRASOUND THERAPY;
ANTIOXIDANTS;
BENZENESULFONATES;
CEREBROVASCULAR ACCIDENT;
FIBRINOLYTIC AGENTS;
HUMANS;
MAGNETIC RESONANCE IMAGING;
NITROGEN OXIDES;
TISSUE PLASMINOGEN ACTIVATOR;
ULTRASONIC THERAPY;
|
EID: 33645733598
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.295.14.1629 Document Type: Short Survey |
Times cited : (3)
|
References (0)
|